Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merchant Group is a boutique investment and financial services firm based in Perth, Australia, with a specialized focus on the biotechnology and medical device sectors. The firm is most notable for managing the Merchant Opportunities Fund, an investment vehicle that targets undervalued and high-growth opportunities within the life sciences industry. Merchant Group plays an active role in the Australian healthcare ecosystem, often serving as a cornerstone investor and providing strategic advisory services to ASX-listed companies. Their portfolio includes significant holdings in firms focused on oncology, regenerative medicine, and diagnostic technologies. By providing critical capital and industry expertise, Merchant Group facilitates the clinical development and commercialization of innovative medical therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merchant Group.